1EMZ - Header Asymmetric Unit

HEADER VIRAL PROTEIN 20-MAR-00 1EMZ

TITLE SOLUTION STRUCTURE OF FRAGMENT (350-370) OF THE TITLE 2 TRANSMEMBRANE DOMAIN OF HEPATITIS C ENVELOPE GLYCOPROTEIN TITLE 3 E1

COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENVELOPE GLYCOPROTEIN E1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: TRANSMEMBRANE DOMAIN (RESIDUES 350-370); COMPND 5 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. SOURCE 4 THE SEQUENCE OF THIS PEPTIDE IS NATURALLY FOUND IN SOURCE 5 HEPATITIS C VIRUS.

KEYWDS PEPTIDE, TRANSMEMBRANE DOMAIN, ENVELOPE PROTEIN E1, KEYWDS 2 HEPATITIS C VIRUS, VIRAL PROTEIN

EXPDTA SOLUTION NMR

AUTHOR A.OP DE BEECK,R.MONTSERRET,S.DUVET,L.COCQUEREL,R.CACAN, AUTHOR 2 B.BARBEROT,M.LE MAIRE,F.PENIN,J.DUBUISSON

REVDAT 3 24-FEB-09 1EMZ 1 VERSN REVDAT 2 29-NOV-00 1EMZ 1 JRNL REVDAT 1 05-APR-00 1EMZ 0

JRNL AUTH A.OP DE BEECK,R.MONTSERRET,S.DUVET,L.COCQUEREL, JRNL AUTH 2 R.CACAN,B.BARBEROT,M.LE MAIRE,F.PENIN,J.DUBUISSON JRNL TITL THE TRANSMEMBRANE DOMAINS OF HEPATITIS C VIRUS JRNL TITL 2 ENVELOPE GLYCOPROTEINS E1 AND E2 PLAY A MAJOR ROLE JRNL TITL 3 IN HETERODIMERIZATION. JRNL REF J.BIOL.CHEM. V. 275 31428 2000 JRNL REFN ISSN 0021-9258 JRNL PMID 10807921 JRNL DOI 10.1074/JBC.M003003200

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER A.T. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURE IS BASED ON 337 NOE REMARK 3 DERIVED DISTANCE CONSTRAINTS

REMARK 4 REMARK 4 1EMZ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-MAR-00. REMARK 100 THE RCSB ID CODE IS RCSB010735.

REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 5.7 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 4 MM E1(350-370), 50% H2O, REMARK 210 50% D2 TRIFLUOROETHANOL (V/V) REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : DQF-COSY, TOCSY, 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : UNITYPLUS REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMR 6.1, X-PLOR 3.1 REMARK 210 METHOD USED : DISTANCE GEOMETRY, SIMULATED REMARK 210 ANNEALING, MOLECULAR DYNAMIC, REMARK 210 ENERGY MINIMIZATION REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : BACK CALCULATED DATA AGREE REMARK 210 WITH EXPERIMENTAL NOESY REMARK 210 SPECTRUM,STRUCTURES WITH THE REMARK 210 LEAST RESTRAINT VIOLATIONS, REMARK 210 STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: SODIUM 2,2 DIMETHYL-2-SILAPENTANE-5-SULFONATE (DSS) IN REMARK 210 THE INTERNAL NMR REFERENCE

REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.

DBREF 1EMZ A 1 21 UNP Q9Q3N3 Q9Q3N3_9HEPC 350 370

SEQRES 1 A 21 GLY ALA HIS TRP GLY VAL LEU ALA GLY ILE ALA TYR PHE SEQRES 2 A 21 SER MET VAL GLY ASN TRP ALA LYS

HELIX 1 1 HIS A 3 LYS A 21 1 19

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000